Author: sklarz

We are much obliged to the Board of Trustees of the U.S-Israel Binational Science Foundation (BSF) for voting to fund our application titled, “Uncovering potential modulation of age-related transcriptional states in tumors and their microenvironment in clinical metastatic breast cancer“

We are much obliged to the Board of Trustees of the Israel Cancer Research Fund (ICRF) for voting to fund our application entitled, “Minimal Transcriptional Archetypes of Drug-Resistance in ER+ Metastatic Breast Cancer.”

Congratulations to Eden on completing her outstanding poster presentation! This project, undertaken during the final year of her undergraduate studies, showcases not only her academic prowess but also her ability to synthesize and communicate complex ideas effectively. Eden’s dedication to her research and her skill in presenting her findings in a visually compelling format are…

Heartfelt congratulations to Dr. Ismaell Massalha on achieving board certification in Oncology! Your dedication and hard work have paid off, marking a significant milestone in your medical career. This accomplishment not only demonstrates your expertise in cancer care but also your commitment to providing the highest standard of treatment to your patients. We’re proud of…

Hoday Haimov – Uncovering Transcriptional Signatures of Differential Drug Response in Archetypical Malignant States in Metastatic Breast Cancer Ismaell Massalha with 2 posters:Deciphering the Role of HCN Gene as  a biomarker in ImmunotherapyAnd –Developing a Machine Learning-Based System  for Early Detection of Fatal Infections in Cancer Patients

Prediction of clinical response – from “big data” in medical informatics to the challenge of predicting treatment response in drug-resistant tumors.